Search

everythinglearnresearchcommunity

for

Search:↓

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Total glucosides of paeony may help treat alopecia areata by reducing inflammation and hair loss.

Mini pulse corticosteroid therapy with oral dexamethasone is effective and has fewer side effects for treating extensive alopecia areata.

Calancardin B may help reduce inflammation in immune cells.

The document concludes that corticosteroids effectively treat vasculitis allergica in over 90% of cases, with long-term kidney issues being the main adverse outcome.

A patient with granuloma annulare experienced both isotopic and isomorphic responses, with skin lesions responding to steroids but relapsing after stopping treatment.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Ustekinumab effectively treated psoriasis and ulcerative colitis in a teen after infliximab caused complications.

Allopurinol may cause rare granulomatous microscopic colitis.

Papulopustular rosacea is an inflammatory skin condition treatable with lifestyle changes and medications.

This type of hair loss is probably often missed and treatments reducing inflammation might work well.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.

Platelet-released growth factors can reduce inflammation in joint disease.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

The treatment was effective for lupus nephritis with manageable side effects.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

DPCP helps treat severe hair loss, but 5% minoxidil doesn't add benefits.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

A 940nm laser effectively reduces inflammation in rat joints.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.